Key QQ1 2024 metrics (CAD, all figures in thousands unless stated):
- Revenue: N/A (no reported revenue in QQ1 2024). In the related quarter-level data, gross-related inputs imply minimal revenue activity in Q1 2024, with gross profit reported as negative where applicable due to cost allocations.
- Gross Profit: -21.9 (Q1 2024 pro forma per quarter data) with a gross margin of -N/A (no revenue). QoQ change: -170.69% (as reported in earnings metrics).
- EBITDA: -1,265.0; EBITDA is a proxy for cash profitability before non-cash items and financing structure adjustments.
- Operating Income: -1,259.0; Operating margin effectively 0% given nil revenue data, but negative due to expense base.
- Net Income: -5,306.0; Net income declined QoQ and YoY (YoY: -142.3%; QoQ: -133.8%), reflecting ongoing R&D/G&A burn without top-line revenue.
- EPS (diluted/GAAP): Not reported for QQ1 2024.
- Operating Cash Flow: -1,475.0; Free Cash Flow: -1,475.0 (negative cash conversion from operations).
- Financing: +3,481.0; Net cash provided by financing activities supported the cash balance.
- Cash and equivalents: CAD 4,415.0 at period end; Cash end balance: CAD 3,822.0 (after other cash movements).
- Balance sheet health: Total assets CAD 6,818.0; Total liabilities CAD 22,960.0; Total stockholders’ equity CAD -16,142.0 (negative equity).
- Liquidity ratios: Current 2.85x; Quick 1.97x; Cash ratio 1.92x; Net debt position: CAD -4,327.0 (net cash). Enterprise value: CAD 3.42x (EV multiple).